Skip to main content

9 Assay for Serum Glycated Lipoproteins

  • Protocol
Atherosclerosis

Part of the book series: Methods in Molecular Medicineā„¢ ((MIMM,volume 52))

  • 540 Accesses

Abstract

Modified low density lipoprotein (LDL) is considered to be a risk factor for the development and progression of atherosclerosis (1-3). Glycated LDL and oxidized LDL are the only modified lipoproteins that exist naturally in the human body, but oxidized LDL does not exist in the circulation because of the presence of many antioxidizing agents (4). LDL cannot be oxidized until it has entered the arterial wall from the circulation. The only modified LDL that exists in the circulation is glycated LDL. It has been shown to be more easily oxidized than native LDL (5-7). These findings indicate that the glycation of LDL may be the initial step in the development of atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lyons, T. J. (1991) Oxidized low density lipoproteins-A role in the pathogenesis of atherosclerosis in diabetes? Diabet. Med. 8, 411ā€“419.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  2. Makita, T., Tanaka, A., Nakajima, K., Nakano, T., and Numano, N. (1999) Importance of glycation in acceleration of low density lipoprotein (LDL) uptake into macrophages in patients with diabetes mellitus. Int. Angiol. 18, 149ā€“153.

    CASĀ  PubMedĀ  Google ScholarĀ 

  3. Makita, T., Tanaka, A., and Numano, F.(1999) Effect of glycated low density lipoprotein on smooth muscle cell proliferation. Int. Angiol., in press.

    Google ScholarĀ 

  4. Colaco, C. A. L. S. and Roser, B. J.(1994) Atherosclerosis and glycation. Bio As says 16, 145ā€“147.

    CASĀ  Google ScholarĀ 

  5. Lyon, T. J. (1992) Lipoprotein glycation and its metabolic consequences. Diabetes 41, 67ā€“73.

    Google ScholarĀ 

  6. Wolff, S. P. and Dean, R. T.(1987) Glucose autoxidation and protein modification;the potential role of autoxidative glycation in diabetes mellitus. Biochem. J. 245, 243ā€“250.

    CASĀ  PubMedĀ  Google ScholarĀ 

  7. Mullarkey, C. J., Edelstein, D., and Brownlee, M. (1990) Free radical generation by early glycation products; a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173, 932ā€“939.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  8. Gonen, B., Baenziger, J., Schonfeld, G., Jacobson, D., and Farrar, P. (1981) Nonenzymatic glycosylation of low density lipoproteins in vitro. Effects on cellinteractive properties. Diabetes 30, 875ā€“878.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  9. Schleicher, E., Deufel, T., and Wieland, O. H. (1981) Non-enzymatic glycosylation of human serum lipoproteins. FEBS Lett. 129, 1ā€“4.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  10. Lopes-Virella, M. F. R., Klein, R. L., Lyons, T. J., Stevenson, H. C., and Witzum, J. L. (1988) Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 37, 550ā€“557.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  11. Gould, B. J., Hall, M., and Cook, J. G. H. (1984) A sensitive method for the measurement of glycosylated plasma proteins using affinity chromatography. Ann. Clin. Biochem. 21, 16ā€“21.

    CASĀ  PubMedĀ  Google ScholarĀ 

  12. Dhima, K., Ito, N., Abe, F., Hirota, M., Yano, M., Yamamoto, Y., Uchida, T., and Noguchi, K. (1988) High performance liquid chromatography assay of serum glycated albumin. Diabetology 31, 327ā€“631.

    Google ScholarĀ 

  13. Tanaka, A., Yui, K., Tomie, N., Baba, T., Tamura, M., Makita, T., Numano, F., Nakatani, S., and Kato, Y. (1997) New assay for glycated lipoproteins by highperformance liquid chromatography. Ann. N.Y. Acad. Sci. 811, 385ā€“394.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  14. Okazaki, M., Sasamoto, K., Muramatsu, T., and Hosaki, S. (1997) Analysis of plasma lipoproteins by gel permeation chromatography, in Handbook of Lipoprotein Testing. (Rifai, N., ed.), AACC press, Washington, DC, pp. 531ā€“548.

    Google ScholarĀ 

  15. Numano, F., Tanaka, A., Makita, T., and Kishi, Y. (1997) Glycated lipoprotein and atherosclerosis. Ann. N.Y. Acad. Sci. 811, 100ā€“114.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

Ā© 2001 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Tanaka, A. (2001). 9 Assay for Serum Glycated Lipoproteins. In: Drew, A.F. (eds) Atherosclerosis. Methods in Molecular Medicineā„¢, vol 52. Humana Press. https://doi.org/10.1385/1-59259-073-X:105

Download citation

  • DOI: https://doi.org/10.1385/1-59259-073-X:105

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-751-9

  • Online ISBN: 978-1-59259-073-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics